Blood test study for people with inherited cancer risk
Part of Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This study looks for DNA fragments in blood of people with certain inherited cancer syndromes. It may help find cancer earlier or guide better monitoring. You would give blood samples every 4 months (if in the experimental group).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed inherited cancer syndrome (like Lynch, HBOC, NF1, LFS, PALB2, or HDGC).
- You are already in a regular cancer screening program with your doctor.
- You do not have a cancer diagnosis or treatment in the last 3 years.
- You are not being tested currently for a suspected cancer.
- You can commit to giving a blood sample three times a year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
Hear when a new Hereditary Cancer Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.